Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph A Lewnard

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
Plos Computational Biology|July 27, 2019
Heterogeneous susceptibility to rotavirus infection and gastroenteritis in two birth cohort studies: Parameter estimation and epidemiological implicationsJoseph A Lewnard, Benjamin A Lopman, Umesh D Parashar, et al.
JAMA Network Open|September 15, 2021
Risk Factors Associated With SARS-CoV-2 Infection Among Farmworkers in Monterey County, CaliforniaAna M Mora, Joseph A Lewnard, Katherine Kogut, et al.
The Lancet. Infectious Diseases|March 18, 2023
Effectiveness of nirmatrelvir-ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care systemJoseph A Lewnard, John M McLaughlin, Debbie Malden, et al.
Medrxiv : the Preprint Server for Health Sciences|October 14, 2022
Effectiveness of nirmatrelvir-ritonavir against hospital admission or death: a cohort study in a large US healthcare systemJoseph A Lewnard, John M McLaughlin, Debbie Malden, et al.
Lancet (London, England)|May 26, 2024
Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysisJoseph A Lewnard, Esmita Charani, Alec Gleason, et al.
Medrxiv : the Preprint Server for Health Sciences|August 15, 2020
The effect of school closures and reopening strategies on COVID-19 infection dynamics in the San Francisco Bay Area: a cross-sectional survey and modeling analysisJennifer R Head, Kristin Andrejko, Qu Cheng, et al.
Plos Computational Biology|December 4, 2020
The DIOS framework for optimizing infectious disease surveillance: Numerical methods for simulation and multi-objective optimization of surveillance network architecturesQu Cheng, Philip A Collender, Alexandra K Heaney, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 28, 2019
Early Evidence of Inactivated Enterovirus 71 Vaccine Impact Against Hand, Foot, and Mouth Disease in a Major Center of Ongoing Transmission in China, 2011-2018: A Longitudinal Surveillance StudyJennifer R Head, Philip A Collender, Joseph A Lewnard, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2024
PNEUMOCOCCAL SEROTYPE DISTRIBUTION AND COVERAGE OF EXISTING AND PIPELINE PNEUMOCOCCAL VACCINESLaura M King, Kristin L Andrejko, Miwako Kobayashi, et al.
The Journal of Infectious Diseases|July 22, 2025
Pneumococcal serotype distribution and coverage of existing and pipeline pneumococcal vaccinesLaura M King, Kristin L Andrejko, Miwako Kobayashi, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
Plos Computational Biology|July 27, 2019
Heterogeneous susceptibility to rotavirus infection and gastroenteritis in two birth cohort studies: Parameter estimation and epidemiological implicationsJoseph A Lewnard, Benjamin A Lopman, Umesh D Parashar, et al.
JAMA Network Open|September 15, 2021
Risk Factors Associated With SARS-CoV-2 Infection Among Farmworkers in Monterey County, CaliforniaAna M Mora, Joseph A Lewnard, Katherine Kogut, et al.
The Lancet. Infectious Diseases|March 18, 2023
Effectiveness of nirmatrelvir-ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care systemJoseph A Lewnard, John M McLaughlin, Debbie Malden, et al.
Medrxiv : the Preprint Server for Health Sciences|October 14, 2022
Effectiveness of nirmatrelvir-ritonavir against hospital admission or death: a cohort study in a large US healthcare systemJoseph A Lewnard, John M McLaughlin, Debbie Malden, et al.
Lancet (London, England)|May 26, 2024
Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysisJoseph A Lewnard, Esmita Charani, Alec Gleason, et al.
Medrxiv : the Preprint Server for Health Sciences|August 15, 2020
The effect of school closures and reopening strategies on COVID-19 infection dynamics in the San Francisco Bay Area: a cross-sectional survey and modeling analysisJennifer R Head, Kristin Andrejko, Qu Cheng, et al.
Plos Computational Biology|December 4, 2020
The DIOS framework for optimizing infectious disease surveillance: Numerical methods for simulation and multi-objective optimization of surveillance network architecturesQu Cheng, Philip A Collender, Alexandra K Heaney, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 28, 2019
Early Evidence of Inactivated Enterovirus 71 Vaccine Impact Against Hand, Foot, and Mouth Disease in a Major Center of Ongoing Transmission in China, 2011-2018: A Longitudinal Surveillance StudyJennifer R Head, Philip A Collender, Joseph A Lewnard, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2024
PNEUMOCOCCAL SEROTYPE DISTRIBUTION AND COVERAGE OF EXISTING AND PIPELINE PNEUMOCOCCAL VACCINESLaura M King, Kristin L Andrejko, Miwako Kobayashi, et al.
The Journal of Infectious Diseases|July 22, 2025
Pneumococcal serotype distribution and coverage of existing and pipeline pneumococcal vaccinesLaura M King, Kristin L Andrejko, Miwako Kobayashi, et al.
Pageof 13